A 16 month old boy with stage IV neuroblastoma and hypoalbuminaemia presented with a left sided haemorrhagic pleural effusion. He subsequently developed generalised oedema. You wonder if there was a role of albumin infusion in correcting hypoalbuminaemia and colloid osmotic pressure (COP), in order to treat the extravasation of fluid into tissue spaces.
In order to give the best care to patients and families, paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions of the family. 1 Archimedes seeks to assist practising clinicians by providing "evidence based" answers to common questions which are not at the forefront of research but are at the core of practice. They are based on an original format from the Journal of Accident and Emergency Medicine. 2 A word of warning. These best evidence topic summaries (BETs) are not systematic reviews, though they are as exhaustive as a practising clinician can produce. They make no attempt to statistically aggregate the data, nor search the grey, unpublished literature. What Archimedes offers are practical, best evidence based answers to practical, clinical questions.
Each topic follows the same format. A description of the clinical setting is followed by a structured clinical question. (These aid in focusing the mind, assisting searching, 3 and gaining answers. 4 ) A brief report of the search used follows-this has been performed in a hierarchical way, to search for the best quality evidence to answer the question. 5 A table provides a summary of the evidence and key points of the critical appraisal. For further information on critical appraisal, and the measures of effect (such as number needed to treat, NNT), books by Sackett 6 and Moyer 7 may help. A commentary is provided to pull the information together, and for accessibility, a box provides the clinical bottom lines.
Readers wishing to submit their own questions-with best evidence answers-are encouraged to read the Instructions for Authors at http://www.archdischild.com. Three topics are covered in this issue of the journal.
The good, the bad, and the unhelpful How can we quantify the likely benefits and harms of treatments? For each treatment we have, there is a series of outcomes; we can calculate the "number needed to treat" (NNT) for good outcomes and "number needed to harm" (NNH) for adverse events. For antibiotic treatment of otitis media, there is an NNT ∼7 to prevent pain at 48 hours, and an NNH ∼7 to produce a rash, vomiting, or diarrhoea. Does the simple equivalence of good and bad outcomes mean that the treatment has no overall effect? To make a balanced assessment you should take into account the severity of the outcome. (If the treatment had the effect of preventing death in 1 of 50 cases, but produced vomiting in 1 of 10 cases, it this a treatment which is five times as bad as good?) The weighing of one outcome against another can more formally assess this. The assessment is the "likelihood of being helped over harmed" or LBHH: LBHH = NNT/(NNH × how much worse bad outcome is over good) For example, if a parent believed "vomiting, rash, or diarrhoea" is half as bad as "pain at 48 hours", the LBHH would be 7/(7 × 0.5) = 2. (Antibiotics for otitis media are considered twice as good as bad.) This approach can be used to personalise the evidence to the patient, and make more transparent the process of evidence based decision making. Search strategy and outcome Secondary sources-Cochrane Library (Issue 4, 2000) : "hypoalbuminaemia", seven systematic reviews (one relevant). PubMed clinical queries; LIMIT to English: "albumin" AND "critical illness"-159 references (one meta-analysis of 55 studies, four of which dealt with hypoalbuminaemia); "colloid osmotic pressure" AND "critical illness"-four references (one relevant to question); "hypoalbuminaemia" AND "critical illness"-six references (one relevant to question). See table 1.
Structured clinical question

Commentary
There is a paucity of data in children. However, in critically ill adults a decrease in serum albumin is associated with increased morbidity and mortality. This may represent a disease related alteration in hepatic synthetic function. Albumin contributes up to 80% of COP in healthy subjects; however, its contribution towards COP is only 17% in critically ill individuals (Blunt et al). In adults, the studies suggest that albumin administration has no effect on mortality. In addition, its contribution towards COP is questionable. In fact, there appears to be no significant difference in COP of survivors compared with non-survivors of critical illness. Taken together, this information suggests that low serum albumin may merely be a surrogate marker of disease severity rather than an indicator of low COP. Hence, when treating patients with hypoalbuminaemia, efforts must be focused on correcting the underlying disorder, rather than reversal of hypoalbuminaemia; or, alternatively, on measuring COP directly. There are no such studies in children, but in the systematic reviews the relation between mortality and albumin administration was similar to that described in adults.
We therefore speculate that in children with protracted or critical illness, such as seen in oncological or life threatening disease, the adult relation between albumin, COP, and outcome may also hold. However, this idea should be tested by prospective biochemical study. Search strategy and outcome Cochrane Database of Systematic Reviews-none with children (1). Medline-"magnesium" AND "asthma" AND "child" AND [(double and blind) or placebo]-four pertinent trials in 18 hits. One additional meta-analysis was identified; hospital admission rate was not assessed as an outcome (2) . See table 2.
Three of these four studies of intravenous MgSO 4 in paediatric ED patients with moderate-severe status asthmaticus showed significant reduction in hospitalisation rates compared to controls. (A formal meta-analysis of these trials would give a better quality answer than to simply add up study numbers.) These patients had all already been treated with maximal inhaled β agonist therapy and corticosteroids. The rough similarity of the asthma response rate (ARR) in the three positive trials suggests a real and clinically significant improvement in an obvious clinical endpoint-hospitalisation. MgSO 4 is easy to administer, can be used in conjunction with other therapies, and appears to show a clinical effect within one to two hours.
The Cochrane review combines adults and children, was performed before two of the studies (the Scarfone and 2nd Ciarallo papers) appeared, and did not separate out children in a subgroup analysis in terms of hospitalisation rates (Rowe et al, 2000) . The other systematic review (Alter et al, 2000) did not evaluate hospital admission as an outcome measure. Though difficult to compare severity of patients across studies, all patients were "moderately to severely" affected and very likely to require hospitalisation. Furthermore, given the low cost and lack of any side effects noted across the studies (it will of course take thousands of patients studied to confidently conclude a drug is "safe"), intravenous magnesium may be indicated in paediatric refractory status asthmaticus. A formal systematic review of these studies is needed. M rs A presents with her 6 week old baby, complaining of his excessive and uncontrollable crying behaviour, particularly in the evening and at night. The child is otherwise healthy, thriving, and has a normal weight gain. Following questions regarding the pattern of crying, and associated signs, it is apparent that the child is exhibiting typical colic behaviour. There are clear signs that the continual and excessive crying behaviour is impairing the mother-child relationship, and you consider the child might be at increased risk of harm (or neglect). In discussing the treatment options, Mrs A tells you that her chiropractor has offered to treat her baby for the excessive crying behaviour. She herself has been 
The early prospective study is the first documented evidence to indicate a possible beneficial effect of chiropractic intervention in colic, and as such highlights the need for future RCTs. The RCT reported by Mercer and Nook is only published in abstract form, and the lack of detail prevents scrutiny of its methodology and data analysis. It is therefore not included in the best evidence available for the effectiveness of chiropractic for colic. Both RCTs (Wiberg et al and Olafsdottir et al) were comparable in design and of good quality. The major difference was in the blinding of parents who completed the crying diary (and the symptom improvement score) and therefore in the reduction of parents' bias. This strengthens the trial by Olafsdottir et al, and their conclusion that chiropractic offers no greater efficacy in treating infantile colic than placebo. On the other hand, the positive effects of spinal manipulation reported by Wiberg et al are almost certainly not as beneficial as they would have been had an intention to treat analysis been carried out. All nine dropouts in the dimethicone group were as a result of a worsening of symptoms (and not parents' bias against medication). There were no dropouts in the spinal manipulation group. The first study is a study of effectiveness-it is pragmatic. Parents taking their child to a chiropractor clearly report a significant improvement. By eliminating parental bias, the second study is an efficacy study of chiropractic intervention. Chiropractic itself does not appear to be efficacious. An alternative explanation for these disparate results is postulated by Grunnet-Nilsson and Wiberg who hypothesise a dose-response phenomenon. In the trial by Olafsdottir et al, a treatment protocol of a maximum of three sessions of spinal manipulation was used over eight days, whereas the study by Wiberg et al relied on the clinical judgement of the chiropractor. All infants received three to five sessions of chiropractic over a 14 day period (64% greater than three). Again this reflects the pragmatic nature of the study by Wiberg et al, and the investigation of effectiveness as opposed to efficacy of a treatment intervention.
c CLINICAL BOTTOM LINE • The evidence suggests that chiropractic has no benefit over placebo in the treatment of infantile colic. However, there is good evidence that taking a colicky infant to a chiropractor will result in fewer reported hours of colic by the parents.
• In this clinical scenario where the family is under significant strain, where the infant may be at risk of harm and possible long term repercussions, where there are limited alternative effective interventions, and where the mother has confidence in a chiropractor from other experiences, the advice is to seek chiropractic treatment.
